Home › Lymphangioleiomyomatosis › New York
Lymphangioleiomyomatosis clinical trials in New York
3 studies for Lymphangioleiomyomatosis are looking for participants at sites in New York.
TSC Biosample Repository and Natural History Database
- New York University Medical Center, New York
- University of Rochester Medical Center, Rochester
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2026 · NCT05676099Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 to 64 · Women · Updated Jan 21, 2026 · NCT06889168Safety and Durability of Sirolimus for Treatment of LAM
- University of Rochester Medical Center, Rochester
RecruitingObservational study
Ages 18 and older · Women · Updated Dec 24, 2024 · NCT02432560From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.